FidoCure®
Precision Medicine for Canine Cancer
• DNA sequencing diagnostic in a CLIA certified lab
• Telemedicine-enabled clinical guidance in conjunction with knowledge of tumor histology
• Facilitated access to targeted therapy, FDA approved for humans
• Administered orally at your clinic or the patient’s home
• Complies with USP 800
Differentiate your practice with advanced, personalized canine cancer care.
The options to treat canine cancer are often limited, while pet parents are increasingly willing to do more for their dogs. FidoCure® enables veterinarians to differentiate their practice with advanced, personalized canine cancer care, previously only available for humans.
Human Oncology
1.6M New Annual Cases
84+ Targeted Therapies in use
Veterinary Oncology
6M New Annual Cases
1 Targeted Therapy
FidoCure Services
- DNA sequencing helps identify the cancer’s mutations to better inform the diagnosis.
- Veterinarians receive a DNA Report and targeted therapy treatment plan.
- FidoCure facilitates access to recommended oral targeted therapies.
- Recommended therapies are FDA-approved and easy to administer at home.
- Offers alternatives to more invasive treatment or a new option when traditional therapies fail.
- Veterinarians receive a Data-Based Report with information about the diagnosis and recommended therapies.
- In cases such as MCT and TCC/UC that already have widely adopted therapies, veterinarians can choose to receive expedited access to therapy.
- Because many MCTs are c-Kit driven and TCCs are BRAF+, FidoCure facilitates access to a c-Kit targeted therapy or EGFR/HER2 and/or MEK targeted therapy.
- Oral therapies are FDA-approved, easy to administer at home and offer an alternative to more invasive treatment or a new option when traditional therapies fail.
Why Offer FidoCure® to Families
“ Almost every cancer in humans is treated with one or a number of different targeted therapies. We believe that that’s going to be the case for veterinary oncology in the near future.”
— Dr. Gerald Post · DVM MEM DACVIM
Chief Veterinary Officer, One Health Company
Thousands of dogs have benefitted from FidoCure® options, many of which had limited other options.
Dr. Aarti Sabhlok
DVM, DACVIM
“It narrows it down a little bit and gives me additional options and sometimes they’re drugs I wouldn’t have thought to use for that particular patient or that particular cancer.”
Dr. Brooke Fowler
DVM MS DACVIM
“FidoCure® is advancing the field of veterinarian oncology by providing the technology to help vet oncologists pinpoint the genetic mutation that may be causing a dog's cancer and providing treatment alternatives that use the latest advances in human oncology.”
Dr. Rob Proietto
VMD, MS
“All of our cases have done tremendous so far so I am hopeful for a long quality of life ahead”